MS-275
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- HDAC inhibitor
- Produktmerkmale
- Potent HDAC inhibitor. Selective for HDAC1 (IC50 = 300 nM) over HDAC3 (IC50 = 8 μM) and HDAC8 (IC50 > 100 μM). In vivo, MS-275 has been shown to inhibit tumor growth via induction of the tumor supressors p21WAF1/CIP1 and gelsolin and to block cell proliferation in a variety of cancer cell lines. The compound has also shown significant anti-rheumatic activity in rat and mouse arthritis models.
- Reinheit
- >98 %
- Formel
- C21H20N4O3
- Löslichkeit
- Soluble in DMSO (up to 25 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- -20 °C
-
- Hintergrund
- Entinostat,Epigenetics,Proliferation,Protein deacetylase,Inflammation,Cancer,Posttranslational modification,Chromatin
- Molekulargewicht
- 376.42
- CAS-Nummer
- 209783-80-2
-